EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy

被引：0

作者：

Kostine, M. ^{[1
]}

Finckh, A. ^{[2
]}

Bingham, C. O. ^{[3
]}

Visser, K. ^{[4
]}

Leipe, J. ^{[5
]}

Schulze-Koops, H. ^{[6
]}

Choy, E. ^{[7
]}

Benesova, K. ^{[8
]}

Radstake, T. ^{[9
]}

Cope, A. ^{[10
]}

Lambotte, O. ^{[11
]}

Gottenberg, J-E. ^{[12
]}

Allenbach, Y. ^{[13
]}

Jamal, S. ^{[14
]}

Marabelle, A. ^{[15
]}

Larkin, J. M. G. ^{[16
]}

Haanen, J. B. A. G. ^{[17
]}

Calabrese, L. ^{[18
]}

Mariette, X. ^{[19
]}

Schaeverbeke, T. ^{[1
]}

机构：

[1] CHU Bordeaux Pellegrin, Rheumatol, Bordeaux, France

[2] Univ Hosp Geneva, Rheumatol, Geneva, Switzerland

[3] Johns Hopkins Univ, Rheumatol, Baltimore, MD USA

[4] Haga Hosp, Rheumatol, The Hague, Netherlands

[5] Univ Med Ctr Mannheim, Rheumatol, Mannheim, Germany

[6] Univ Munich, Rheumatol Clin Immunol, Munich, Germany

[7] Cardiff Univ, Rheumatol, Sch Med, Cardiff, S Glam, Wales

[8] Univ Hosp Heidelberg, Rheumatol, Heidelberg, Germany

[9] Univ Med Ctr Utrecht, Translat Immunol, Utrecht, Netherlands

[10] Kings Coll London, Rheumatol, London, England

[11] CHU Bicetre, Internal Med, Le Kremlin Bicetre, France

[12] Univ Hosp Strasbourg, Rheumatol, Strasbourg, France

[13] Hop La Pitie Salpetriere, Internal Med, Paris, France

[14] Univ British Columbia, Rheumatol, Vancouver, BC, Canada

[15] Inst Gustave Roussy, Drug Dev Dept, Villejuif, France

[16] Royal Marsden Hosp NHS Fdn Trust, Med, London, England

[17] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Med Oncol, Amsterdam, Netherlands

[18] Cleveland Clin, Rheumatol Immunol, Cleveland, OH 44106 USA

[19] CHU Paris Sud, Hop Bicetre, Rheumatol Immunol, Le Kremlin Bicetre, France

来源：

ANNALS OF ONCOLOGY | 2019年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1298P

引用

页码：528 / 528

页数：1

共 50 条

[1] EULAR RECOMMENDATIONS FOR THE DIAGNOSIS AND THE MANAGEMENT OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS DUE TO CANCER IMMUNOTHERAPY
Kostine, Marie
Finckh, Axel
Bingham, Clifton
Visser, Karen
Leipe, Jan
Schulze-Koops, Hendrik
Choy, Ernest
Benesova, Karolina
Radstake, Timothy R.
Cope, Andrew
Lambotte, Oliver
Gottenberg, Jacques-Eric
Allenbach, Yves
Visser, Marianne
Rusthoven, Cindy
Thomasen, Lone
Jamal, Shahin
Marabelle, Aurelien
Larkin, James
Haanen, John
Calabrese, Leonard
Mariette, Xavier
Schaeverbeke, Thierry
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 158 - 158
[2] EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
Kostine, Marie
Finckh, Axel
Bingham, Clifton O., III
Visser, Karen
Leipe, Jan
Schulze-Koops, Hendrik
Choy, Ernest H.
Benesova, Karolina
Radstake, Timothy R. D. J.
Cope, Andrew P.
Lambotte, Olivier
Gottenberg, Jacques-Eric
Allenbach, Yves
Visser, Marianne
Rusthoven, Cindy
Thomasen, Lone
Jamal, Shahin
Marabelle, Aurelien
Larkin, James
Haanen, John B. A. G.
Calabrese, Leonard H.
Mariette, Xavier
Schaeverbeke, Thierry
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01) : 36 - 48
[3] Immune-Related Adverse Events Due to Cancer Immunotherapy
Benesova, Karolina
Leipe, Jan
AKTUELLE RHEUMATOLOGIE, 2020, 45 (06) : 535 - 543
[4] Rheumatic immune-related adverse events from cancer immunotherapy
Calabrese, Leonard H.
Calabrese, Cassandra
Cappelli, Laura C.
NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) : 569 - 579
[5] Rheumatic immune-related adverse events from cancer immunotherapy
Leonard H. Calabrese
Cassandra Calabrese
Laura C. Cappelli
Nature Reviews Rheumatology, 2018, 14 : 569 - 579
[6] Immunotherapy - immune-related adverse events and their management
Petrausch, Ulf
THERAPEUTISCHE UMSCHAU, 2019, 76 (04) : 195 - 198
[7] Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors—is it time for a paradigm shift?
Katerina Chatzidionysiou
Matina Liapi
Georgios Tsakonas
Iva Gunnarsson
Anca Catrina
Clinical Rheumatology, 2021, 40 : 1687 - 1695
[8] Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
Olsen, T. Anders
Zhuang, Tony Zibo
Caulfield, Sarah
Martini, Dylan J.
Brown, Jacqueline T.
Carthon, Bradley C.
Kucuk, Omer
Harris, Wayne
Bilen, Mehmet Asim
Nazha, Bassel
FRONTIERS IN ENDOCRINOLOGY, 2022, 13
[9] Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations
Casagrande, Silvia
Sopetto, Giulia Boscato
Bertalot, Giovanni
Bortolotti, Roberto
Racanelli, Vito
Caffo, Orazio
Giometto, Bruno
Berti, Alvise
Veccia, Antonello
CANCERS, 2024, 16 (07)
[10] Testing Immune-Related Adverse Events in Cancer Immunotherapy
Farmer, Jocelyn R.
CLINICS IN LABORATORY MEDICINE, 2019, 39 (04) : 669 - +

← 1 2 3 4 5 →